Product catalog
contact us

    KCI BioTech (Suzhou) Inc.
    Tel:0512-69998806
    Ministry of Commerce:0512-69998806-8012
    BD:
    East and South China:Ms. Gu 15378638068
    North China, East China:Mr. Han 18914988667
    Central and Western regions: Ms. Xiang 15828112963
    Project Management Department:0512-69998806-8022
    Tumor business:0512-69998806-8058
    Non tumor business:0512-69998806-8026
    Pathogenic microorganism business:0512-69998806-8037
    Integrated Service Platform:0512-69998806-8022
    Address: Building A2, Xinyang Industrial Park, No. 8 Yanghua Road, Suzhou Industrial Park

Key Model for Drug Development of Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is a common chronic disease characterized by airflow obstruction with chronic bronchitis and/or emphysema, which can further progress to pulmonary heart disease and respiratory failure. It is associated with an abnormal inflammatory response to noxious gases and harmful particles, with high rates of disability and mortality.
  We have established a stable smoking+lipopolysaccharide (LPS)-induced COPD model, which is suitable for preclinical COPD drug research and new drug evaluation.
  If you have a project need and experience more of our professional services, please contact us.

Our services

Model classification

Model Name

Animal species

Chronic obstructive pulmonary disease

COPD induced by smoking + lipopolysaccharide (LPS)

Mice,golden gophers


Case sharing

Previous:Cough
Next:Silicosis